Abstract
In spite of major research and development efforts in transdermal systems and the many advantages of the transdermal route, impermeability of the human skin is still a major problem that limits the usefulness of the transdermal approach. It is well accepted that the stratum corneum is the major rate-limiting barrier to molecular diffusion through the mammalian epidermis.1,2 Because most drugs do not permeate the skin in therapeutic amounts, chemical and physical approaches have been examined to lower the stratum corneum barrier properties and enhance transdermal permeation.3,4
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev. 1971;51:702–747.
Bartek M, LaBudde J, Maibach H. Skin permeability in vitro: Comparison in rat, rabbit, pig and man. J Invest Dermatol. 1972;58:114.
Rolf D. Chemical and physical methods of enhancing transdermal drug delivery. Pharm Technol. 1988(Sept.);130–139.
Hadgraft J, Guy RH. Transdermal Drug Delivery. New York Marcel Dekker; 1989.
Walters KA. Penetration enhancers and their use in transdermal therapeutic systems. In: Hadgraft J, Guy HG, eds. Transdermal Drug Delivery: Developmental Issues and Research Initiatives. Marcel Dekker; 1989:197–246.
Skauen DM, Zentner GM. Phonophoresis. Int J Pharm. 1984;20:235–245.
Quillen WS. Phonophoresis: A review of the literature and technique. Athl Train. 1980; 15:109–110.
Tyle P, Agrawala P. Drug delivery by phonophoresis. Pharm Res. 1989;6:355–361.
Curie J, Curie P. Compt Rend. 1881;93:1137.
Curie J, Curie P. Compt Rend. 1880;91:294.
Hoogland R. Ultrasound Therapy. Delft, The Netherlands: B. V.. Enraf Nonius Delft, Holland; 1986.
Sislick KS. Ultrasound: Its Chemical, Physical and Biological Effects. Weinheim, Germany: VCH Publishers; 1988.
Mason TJ. Chemistry with Ultrasound. London: Elsevier Applied Science; 1990.
Wells PNT. Biomedical Ultrasonics. New York: Academic Press; 1977.
Fellinger K, Schmid J. Klinik and Therapies des Chromischen Gelenkreumatismus. Maudrich Vienna, Austria: 1954;549–552.
Newman MK, Kill M, Frompton G. The effect of ultrasound alone and combined with hydrocortisone injections by needle or hypospray. Am J Phys Med. 1958;37:206–209.
Coodley GL. Bursitis and post-traumatic lesions. Am Pract. 1960;11:181–187.
Antich TJ. Phonophoresis: The principles of the ultrasonic driving force and efficacy in treatment of common orthopaedic diagnoses. J Ortho Sports Phys Ther. 1982;4:99–102.
Cameroy BM. Ultrasound enhanced local anesthesia. Am J Orthoped. 1966;8:47.
Griffin JE, Echternach JL, Price RE, Touchstone JC. Patients treated with ultrasonic driven hydrocortisone and with ultrasound alone. Phys Ther. 1967;47:594–601.
Moll MA. A new approach to pain. U.S. Armed Forces Med Serv Dig. 1979;30:8–11.
McElnay JC, Matthews MP, Harland R, McCafferty DF. The effect of ultrasound on the percutaneous absorption of lignocaine. Br J Clin Pharm. 1985;20:421–424.
McElnay JC, Kennedy TA, Harland R. The influence of ultrasound on the percutaneous absorption of fluocinolone acetonide. Int J Pharm. 1987;40:105–110.
Benson HAE, McElnay JC, Harland R. Phonophoresis of lignocaine and prilocaine from Emla® cream. Int J Pharm. 1988;44:65–69.
Benson HAE, McElnay JC, McCallion O, Harland R, Murphy TM, Hadgraft J. Influence of ultrasound on the percutaneous absorption of a range of nicotinate esters. J Pharm Pharmacol. 1989;40:40.
Benson HAE, McElnay JC, Harland R, Hadgraft J. Influence of ultrasound on the percutaneous absorption of nicotinate esters. Pharm Res. 1991;8:204–209.
Kleinkort JA, Wood F. Phonophoresis with 1 percent versus 10 percent hydrocortisone. Phys Ther. 1975;55:1320–1324.
Benson HAE, McElnay JC. Transmission of ultrasound energy through topical pharmaceutical products. Physiotherapy. 1988;74:587–589.
Williams AR. Phonophoresis: An in vivo evaluation using three topical anaesthetic preparations. Ultrasonics. 1990;28:137–141.
Eisner P, Maibach HI. Acute sodium lauryl sulfate skin toxicity is not enhanced by phonophoresis. 1991 (submitted).
Tsitlanazde VG. Morphohistochemical changes during experimental arthritis in rabbits caused by hydrocortisone phonophoresis. Soobshch AkadNauk Gruz SSR. 1971;63:237–240.
Griffin JE, Touchstone JC. Effects of ultrasonic frequency on phonophoresis of Cortisol into swine tissues. Am J Phys Med. 1972;51:62.
Griffin JE, Touchstone JS. Ultrasonic movement of Cortisol into pig tissue. I. Movement into skeletal muscle. Am J Phys Med. 1963;42:77–85.
Griffin JE, Touchstone JS. Ultrasonic movement of Cortisol into pig tissue. II. Movement into paravertebral nerve. Am J Phys Med. 1965;44:20–25.
Griffin JE, Touchstone JC. Low-intensity phonophoresis of Cortisol in swine. Phys Ther. 1968;48(12): 1336–1344.
Pratzel H, Dittrich P, Kukovetz W. Spontaneous and forced cutaneous absorption of indomethacin in pigs and humans. J Rheumatol. 1986; 13:1122–1125.
Camel EC, Melenders J, Maibach HI. Effect of ultrasound on the in vivo percutaneous absorption of drugs in the rhesus monkey. 1991 (submitted).
Kremkau FW. Ultrasonic treatment of experimental animal tumors. Br J Cancer. 1982;45(suppl 5):226–232.
Tachibana K, Tachibana S. Transdermal delivery of insulin by ultrasonic vibration. J Pharm Pharmacol. 1991;43:270–271.
Kost J, Levy D, Langer R. Ultrasound Effect on Transdermal Drug Delivery. Norfolk, Virginia: Controlled Release Society; 1986:177–178.
Kost J, Levy D, Langer R. Ultrasound as a Transdermal Enhancer. 2nd ed. New York: Marcel Dekker; 1989:595–601.
Levy D, Kost J, Mashulam Y, Langer R. Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. J Clin Invest. 1989;83:2074–2078.
Miyazaki S, Mizuoka H, Oda M, Takada M. External control of drug release and penetration: Enhancement of the transdermal absorption of indomethacin by ultrasound irradiation. J Pharm Pharmacol. 1991;43:115–116.
Bommannan D, Okuyama H, Stauffer P, Guy R. Sonophoresis: Enhancement of Transdermal Drug Delivery Using Ultrasound. Reno, Nevada: Controlled Release Society; 1990.
Bommannan D, Okuyama H, Stauffer P, Guy RH. Sonophoresis. I. The use of ultrasound to enhance transdermal drug delivery. Pharm Res. 1992;9:559–564.
Nanavaty M, Brucks R, Grimes H, Siegel FP. An ATR-FTIR Approach to Study the Effect of Ultrasound on Human Skin. Chicago: Controlled Release Society; 1989:310–311.
Goodman M, Barry BW. Action of skin permeation enhancers azone, oleic acid and decylmethyl sulphoxide: Permeation and DSC studies. J Pharm Pharmacol. 1986;38(suppl):71.
Kost J, Machluf M, Langer R. Experimental Approaches to Elucidate the Mechanism of Ultrasonically Enhanced Transdermal Drug Delivery. Reno, Nevada: Controlled Release Society; 1990:29–30.
Bommannan D, Menon GK, Okuyama H, Elias P, Guy RH. Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res. 1992;9:1043–1047.
Chen YL, Israelachvili J. New Mechanism of cavitation damage. Science. 1991;252:1157–1160.
Mortimer AJ, Trollope BJ, Villneuve EJ, Roy OZ. Ultrasound-enhanced diffusion through isolated frog skin. Ultrasonics. 1988;26:348–351.
Mortimer AJ, Maclean JA. A dosimeter for ultrasonic cavitation. J Ultrasound Med. 1986;5(suppl): 137.
Howkins SD. Diffusion rates and the effect of ultrasound. Ultrasonics. 1969;8:129–130.
Fogler S, Lund K. Acoustically augmented diffusional transport. J Acoust Soc Am. 1973;53:59–64.
Nyborg WL. Acoustic Streaming. New York: Academic Press; 1965:265–332.
Lenart I, Auslander D. The effect of ultrasound on diffusion through membranes. Ultrasonics. 1980;18:216–218.
Julian TN, Zentner GM. Ultrasonically mediated solute permeation through polymer barriers. J Pharm Pharmacol. 1986;38:871–877.
Julian TN, Zentner GM. Mechanism for ultrasonically enhanced transmembrane solute permeation. J Controlled Release. 1990; 12:77–85.
Kost J, Leong K, Langer R. Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc Natl Acad Sci. U.S.A. 1989;86:7663–7666.
Liu L-S, Kost J, D’Emanuele A, Langer R. Experimental approach to elucidate the mechanism of ultrasound-enhanced polymer erosion and release of incorporated substances. Macromolecules. 1992;25:123–128.
D’Emanuele A, Kost J, Hill J, Langer R. An investigation of the effect of ultrasound on degradable polyanhydride matrices. Macromolecules. 1992;25:511–515.
Machluf M, Kost J. Ultrasonically enhanced transdermal drug delivery. Experimental approaches to elucidate the mechanism. J. Biomater. Sci. Polymer. 1993 (in press).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kost, J., Langer, R. (1993). Ultrasound-Mediated Transdermal Drug Delivery. In: Shah, V.P., Maibach, H.I. (eds) Topical Drug Bioavailability, Bioequivalence, and Penetration. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1262-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1262-6_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1264-0
Online ISBN: 978-1-4899-1262-6
eBook Packages: Springer Book Archive